AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Tariff Uncertainty and Healthcare Sector Performance.
ByAinvest
Wednesday, Jul 16, 2025 4:21 pm ET1min read
ASML warned it may not achieve revenue growth in 2026 due to uncertainty surrounding US tariffs. Meanwhile, Johnson & Johnson shares surged after halving its tariff-related costs and raising its full-year sales and profit forecast. The healthcare sector has been underperforming, but J&J's strong results present a value-priced leader in the industry.
ASML Holding NV, the world's leading supplier of chip-making equipment, has warned that it may not achieve revenue growth in 2026 due to uncertainty surrounding US tariffs. The company's shares fell by as much as 11% on Wednesday, reaching a low of €630.70 in Amsterdam, following the announcement [1].ASML's CEO, Christophe Fouquet, stated that while the company continues to prepare for growth in 2026, it cannot confirm it at this stage due to increasing uncertainty driven by macro-economic and geopolitical developments [1]. The company's forecast for third-quarter net sales was between €7.4 billion and €7.9 billion, below the average analyst estimate of €8.2 billion [1].
Meanwhile, Johnson & Johnson shares surged after halving its expectations for tariff-related costs in 2025 and raising its full-year sales and profit forecast. The healthcare giant's shares rose by 6.5% on Wednesday, following the announcement [3].
Johnson & Johnson attributed the reduction in tariff-related costs to the Trump administration's pause on China levies and other duties. The company now expects about $200 million in tariff-related costs this year, down from a previous estimate of about $400 million [3]. J&J's Chief Financial Officer, Joe Wolk, noted that the company was able to absorb those costs and still raise its profit outlook [3].
The healthcare sector has been underperforming, but J&J's strong results present a value-priced leader in the industry. The company beat Wall Street expectations for the second quarter, posting adjusted earnings of $2.29 billion, up from $1.58 billion a year earlier [3].
References:
[1] https://finance.yahoo.com/news/asml-walks-back-2026-growth-061702879.html
[3] https://www.marketscreener.com/quote/stock/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-lifts-2025-forecast-halves-tariff-cost-outlook-50522966/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet